|
Symbol
|
RMALXV | RMADXV | OJSRCH | RMA23V | KYGDDU | KYFWDU | AAAHTQ | KYHHDU | KYDNDU | RMA7AV | AAHKTQ | OMFRCH | OMHRCH | OKKRCH | RMAPGV | RMAMKV | AAGOTQ | RMA7YV | ONYRCH | OQTRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible |
|
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG / Zurich Insurance Group AG | Alcon / Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Novartis AG / Straumann Hldg. AG / UBS Group AG | Nestlé S.A. / Roche PS / UBS Group AG | Compagnie Financière Richemont SA / Kühne & Nagel Intl. AG / Lonza Group N / UBS Group AG | ABB / Sonova Hldg. AG / UBS Group AG / Zurich Insurance Group AG | Companie Financière Richemont SA / Givaudan / UBS Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / UBS Group AG | Nestlé S.A. / Novartis AG / Partners Group Hldg. AG / Roche PS / UBS Group AG | Nestlé S.A. / Roche PS / SGS SA / UBS Group AG | Givaudan / Partners Group Hldg. AG / Sika AG / UBS Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
22.06.2026 | 19.04.2027 | 14.06.2027 | 21.12.2026 | 29.06.2026 | 29.06.2026 | 24.06.2026 | 03.07.2026 | 12.06.2026 | 06.07.2026 | 08.07.2026 | 08.07.2026 | 08.07.2026 | 24.06.2026 | 13.07.2026 | 13.07.2026 | 12.01.2027 | 05.01.2027 | 15.01.2027 | 05.08.2026 |
| Demande | 99,50 | 99,80 | 99,40 | 100,50 | 94,80 | 60,10 | 98,42 | 95,70 | - | 101,40 | 101,02 | 100,28 | 99,23 | 101,26 | 99,40 | 101,60 | 100,76 | 83,80 | 99,83 | 57,65 |
| Offre | 100,30 | 100,60 | 99,90 | 101,30 | 95,80 | 61,10 | - | 96,70 | - | 102,20 | - | - | 100,03 | - | 100,60 | 102,40 | 101,57 | - | 100,63 | - |